Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Shugan Dingtong Decoction for Fibromyalgia
NCT05508516Phase 1Completed
- Sponsor
- China-Japan Friendship Hospital
- Start
- Sep 2022
- Primary completion
- Oct 2024
- Modality
- Traditional Chinese Medicine decoction
- Countries
- 1
01
Overview
Phase 1, randomised trial of Shugan Dingtong decoction in fibromyalgia (FM) (2 arms), sponsored by China-Japan Friendship Hospital. Primary endpoint: Visual Analogue Scale pain scores at 12 weeks. Started Sep 2022; status: completed.
02
Drugs
Shugan Dingtong decoction
03
Conditions
fibromyalgia (FM)
Beyond the preview
Go deeper on NCT05508516.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05508516.